TLRY 0.99 (-5.71%)
US88688T1007Drug ManufacturersDrug Manufacturers - Specialty & Generic

Tilray Brands (TLRY) Competitor Comparison

We are evaluating the key criteria listed to compare Tilray Brands (TLRY) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 3 years - TLRY ranking 38 / 54

These are the competitors of Tilray Brands in the industry Drug Manufacturers - Specialty & Generic ranked by performance 3 years
1. Harrow Health HROW
348.47
2. Teva Pharmaceutical Industries TEVA
114.39
3. Evolus EOLS
98.72
4. Amneal Pharmaceuticals AMRX
90.32
5. Collegium Pharmaceutical COLL
83.33
6. ANI Pharmaceuticals ANIP
49.33
7. Vifor Pharma G2AB.F
39.09
8. Avadel Pharmaceuticals AVDL
35.74
9. Alvotech ALVO
33.89
10. Amphastar Pharmaceuticals AMPH
33.6
11. Supernus Pharmaceuticals SUPN
26.38
12. PetIQ PETQ
26.14
13. Phibro Animal Health PAHC
17.76
14. Kolinpharma KIP.MI
17.3
15. Alimera Sciences ALIM
15.9
16. Kamada KMDA
14.46
17. Journey Medical DERM
-12.16
18. Zoetis ZTS
-12.81
19. Cumberland Pharmaceuticals CPIX
-31.72
20. Perrigo PRGO
-33.86
21. Alpha Teknova TKNO
-41.34
22. Taro Pharmaceutical Industries TARO
-41.5
23. Cronos Group CRON
-43.95
24. Linc LNC
-48.03
25. Organogenesis Holdings ORGO
-48.1
26. Catalent CTLT
-50.02
27. Elanco Animal Health ELAN
-52.82
28. Green Thumb Industries R9U2.F
-55.06
29. Pacira BioSciences PCRX
-57.12
30. Embecta EMBC
-62.65
31. Zynerba Pharmaceuticals ZYNE
-64.48
32. Societal CDMO SCTL
-65.73
33. Bausch Health Companies BHC
-69.12
34. OptiNose OPTN
-73.58
35. Emergent BioSolutions EBS
-74.77
36. Ironwood Pharmaceuticals IRWD
-78.49
37. Jupiter Wellness JUPW
-80
38. Tilray Brands TLRY
-80.91
39. Curaleaf Holdings CURLF
-81.17
40. Solid Biosciences SLDB
-81.4
41. SCYNEXIS SCYX
-85.82
42. ProPhase Labs PRPH
-86.78
43. Regencell Bioscience Holdings RGC
-87.42
44. Theratechnologies THTX
-88.24
45. Ascend Wellness Holdings AAWH
-90
46. Procaps Group PROC
-91.57
47. Neoleukin Therapeutics NLTX
-94.43
48. Ayr Wellness 3KJB.F
-94.43
49. Universe Pharmaceuticals UPC
-96.27
50. Relmada Therapeutics RLMD
-96.32
51. Eagle Pharmaceuticals EGRX
-98.42
52. Flora Growth FLGC
-98.62
53. Biofrontera BFRI
-98.78
54. Clever Leaves Holdings CLVR
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.